Eric Topol
Eric Topol
Professor and EVP, Scripps Research
Verified email at - Homepage
Cited by
Cited by
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
CAPRIE Steering Committee
The Lancet 348 (9038), 1329-1339, 1996
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
Gusto Investigators
New England Journal of Medicine 329 (10), 673-682, 1993
High-performance medicine: the convergence of human and artificial intelligence
EJ Topol
Nature medicine 25 (1), 44-56, 2019
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt, KAA Fox, W Hacke, PB Berger, HR Black, WE Boden, P Cacoub, ...
New England Journal of Medicine 354 (16), 1706-1717, 2006
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial
SR Steinhubl, PB Berger, JT Mann III, ETA Fry, A DeLago, C Wilmer, ...
Jama 288 (19), 2411-2420, 2002
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
Epic Investigators
New England Journal of Medicine 330 (14), 956-961, 1994
Risk of cardiovascular events associated with selective COX-2 inhibitors
D Mukherjee, SE Nissen, EJ Topol
Jama 286 (8), 954-959, 2001
Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review
DP Oran, EJ Topol
Annals of internal medicine 173 (5), 362-367, 2020
Prevalence of conventional risk factors in patients with coronary heart disease
UN Khot, MB Khot, CT Bajzer, SK Sapp, EM Ohman, SJ Brener, SG Ellis, ...
Jama 290 (7), 898-904, 2003
The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
GUSTO Angiographic Investigators
New England Journal of Medicine 329 (22), 1615-1622, 1993
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
Epilog Investigators
New England Journal of Medicine 336 (24), 1689-1697, 1997
Long COVID: major findings, mechanisms and recommendations
HE Davis, L McCorkell, JM Vogel, EJ Topol
Nature Reviews Microbiology 21 (3), 133-146, 2023
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial
SE Nissen, EM Tuzcu, P Libby, PD Thompson, M Ghali, D Garza, ...
Jama 292 (18), 2217-2225, 2004
Chitin chemistry
GAF Roberts, GAF Roberts
macmillan, 1992
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
PURSUIT Trial Investigators
New England Journal of Medicine 339 (7), 436-443, 1998
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy
AT Askari, S Unzek, ZB Popovic, CK Goldman, F Forudi, M Kiedrowski, ...
The Lancet 362 (9385), 697-703, 2003
Recommendations for the standardization and interpretation of the electrocardiogram: part I: the electrocardiogram and its technology: a scientific statement from the American …
P Kligfield, LS Gettes, JJ Bailey, R Childers, BJ Deal, EW Hancock, ...
Circulation 115 (10), 1306-1324, 2007
Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial
MJ Price, PB Berger, PS Teirstein, JF Tanguay, DJ Angiolillo, D Spriggs, ...
Jama 305 (11), 1097-1105, 2011
A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
PA Gum, K Kottke-Marchant, PA Welsh, J White, EJ Topol
Journal of the American College of Cardiology 41 (6), 961-965, 2003
The system can't perform the operation now. Try again later.
Articles 1–20